Published in
Taylor and Francis Group, Current Medical Research and Opinion, 11(20), p. 1747-1752
Links
Tools
An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 